👀 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Silgan shares keep buy rating, steady target amid Coty's market update

EditorNatashya Angelica
Published 10/16/2024, 08:46 AM
SLGN
-

On Wednesday, Truist Securities maintained a Buy rating on Silgan Holdings (NYSE:SLGN) shares, with a steady price target of $59.00. The affirmation comes in the wake of Coty (NYSE:COTY), a notable player in the beauty industry, releasing preliminary financial results for the first quarter of fiscal year 2025, which ended in September.

Coty, which is not rated by Truist Securities, observed that the global beauty market continues to show resilience, although growth has slightly decelerated. The company emphasized the strong performance of the prestige fragrance sector, which is benefiting from increased volumes and a favorable price mix. In contrast, the mass beauty segment is experiencing a downturn, as indicated by declining unit volumes.

The company also pointed out a slowdown in the U.S. market during the latter half of the first quarter, while noting that their products' sell-out rates are surpassing sell-in across various markets, including the U.S., China, and Travel Retail Asia. This trend is attributed to cautious order and inventory management by retailers.

Coty reported that like-for-like (LFL) sales growth for the first quarter was between 4-5% year-over-year, falling short of the projected 6% growth. Looking ahead, Coty anticipates moderate like-for-like sales growth in the second quarter, factoring in the slower U.S. market and ongoing retailer caution in a more uncertain demand environment. The full financial results for Coty's first quarter are scheduled to be released on November 6.

In other recent news, Silgan Holdings has finalized its acquisition of Weener Plastics, broadening its global reach with the addition of 19 facilities. The acquisition is expected to result in operational cost synergies of about €20 million within the next 18 months. It also anticipates a modest positive impact on its adjusted earnings per share for 2024, with a projected 10% increase upon full integration.

In financial developments, Silgan reported strong Q2 2024 performance, buoyed by improving volume trends across all business segments. The company has also announced a quarterly cash dividend of $0.19 per share for the 82nd consecutive quarter.

Regarding analyst notes, JPMorgan upgraded Silgan's stock from Underweight to Neutral, citing strong acquisition potential. The acquisition of Weener Packaging (NYSE:PKG) is projected to contribute approximately $100 million to Silgan's EBITDA in 2025, along with an expected $115 million in adjusted EBITDA. These are the recent developments shaping the trajectory of Silgan Holdings.

InvestingPro Insights

While Truist Securities maintains a Buy rating on Silgan Holdings (NYSE:SLGN) with a $59.00 price target, InvestingPro data provides additional context for investors. Silgan's market cap stands at $5.49 billion, with a P/E ratio of 18.06, suggesting a moderate valuation relative to earnings. The company's revenue for the last twelve months as of Q2 2024 was $5.84 billion, although it experienced a revenue decline of 6.85% during this period.

InvestingPro Tips highlight Silgan's strong shareholder-friendly practices. The company has raised its dividend for 20 consecutive years and has been aggressively buying back shares. This commitment to shareholder returns is further evidenced by a high shareholder yield. Moreover, Silgan's stock is trading near its 52-week high, with a robust 26.49% total return over the past year.

These insights are particularly relevant given the broader context of the beauty industry's performance, as discussed in the article about Coty. While Coty faces challenges in the mass beauty segment and a slowdown in the U.S. market, Silgan's diverse packaging solutions and strong financial discipline may position it well to navigate industry fluctuations.

For investors seeking a more comprehensive analysis, InvestingPro offers 10 additional tips for Silgan Holdings, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.